Home > Reviews > Ipamorelin Review

Ipamorelin Review 2025: Research Grade Analysis

Last Updated: February 2025 | By CellForce Labs Research Team | Contains affiliate links

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide (5 amino acids) that acts as a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R). Unlike earlier GHRPs such as GHRP-6 and GHRP-2, Ipamorelin demonstrates remarkable selectivity for GH release with minimal impact on other hormones. It does not significantly raise cortisol, ACTH, or prolactin at standard research doses, making it the most selective GHRP identified to date. This clean pharmacological profile has made it a preferred choice for researchers studying GH-related pathways without confounding hormonal variables.

Category	Growth Hormone Secretagogue
Also Known As	Ipamorelin Peptide, GHRP
Research Status	Preclinical + clinical studies
Key Function	Selective growth hormone releasing peptide
Half-Life	~2 hours

Research Benefits of Ipamorelin

• Selective GH Release: Stimulates growth hormone secretion without elevating cortisol, prolactin, or ACTH.
• Body Composition: Research shows improved lean body mass and reduced adiposity in animal models.
• Bone Density: Studies demonstrate increased bone mineral content and strength with Ipamorelin treatment.
• Recovery: Enhanced tissue repair and recovery markers when combined with adequate GH secretion.
• Sleep Quality: Growth hormone secretagogues can improve slow-wave sleep patterns, when natural GH pulsing peaks.
• Synergy with CJC-1295: Combined protocols produce amplified GH release through complementary GHRH and GHRP receptor pathways.

Mechanism of Action

Ipamorelin binds to the GHS-R1a receptor on somatotroph cells in the anterior pituitary, triggering GH release through a mechanism distinct from GHRH. While GHRH (and its analog CJC-1295) stimulates GH synthesis and release via the GHRH receptor, Ipamorelin works through the ghrelin receptor pathway. This complementary mechanism explains the synergistic effect when combined with CJC-1295. Ipamorelin also suppresses somatostatin, the GH-inhibiting hormone, further enhancing GH pulsatility. Its selectivity stems from specific receptor binding affinity that avoids stimulating ACTH or prolactin release pathways.

Research Protocols

Parameter	Research Data
Research Dose	100-300 mcg per administration
Frequency	2-3 times daily
Administration	Subcutaneous injection
Common Stack	CJC-1295 (Mod GRF) 100-300 mcg
Best Timing	Pre-sleep, post-exercise, or fasted
Research Duration	8-16 weeks

Visit our Reconstitution Calculator for dosing calculations.

Side Effects & Safety Profile

Ipamorelin has one of the cleanest side effect profiles among growth hormone secretagogues. The most commonly observed effects include mild headache, temporary flushing immediately after injection, and occasional water retention. Its key advantage is the absence of significant cortisol or prolactin elevation, which distinguishes it from earlier GHRPs. Hunger stimulation is minimal compared to GHRP-6. No significant organ toxicity has been reported in published research at standard doses.

Where to Buy Ipamorelin

Vendor	Price	Testing	Rating	Link
Swiss Chems	$34.95 (5mg)	3rd-party HPLC + MS	4.8/5	Buy →
Peptide Sciences	$39.99 (5mg)	3rd-party HPLC	4.7/5	Buy →
Amino Asylum	$24.99 (5mg)	In-house	4.3/5	Buy →

Related Research

• Ipamorelin Benefits
• Ipamorelin Dosage Guide
• Where to Buy Ipamorelin
• CJC-1295 vs Ipamorelin
• Ipamorelin vs Sermorelin
• Best Growth Hormone Peptides

Frequently Asked Questions

What makes Ipamorelin different from other GHRPs?

Ipamorelin is the most selective GHRP, stimulating GH release without significantly raising cortisol, ACTH, or prolactin. This clean profile reduces side effects and confounding variables in research.

Should Ipamorelin be combined with CJC-1295?

Yes, the CJC-1295/Ipamorelin combination is one of the most popular GH research protocols. They work through complementary receptors (GHRH-R and GHS-R) for synergistic GH release.

When is the best time to administer Ipamorelin?

Research protocols typically administer Ipamorelin in a fasted state — commonly pre-sleep, post-exercise, or first thing in the morning — to maximize the GH pulse response.